Product image of Moxonidin Actavis (Moxonidine) supplied by GNH India

Moxonidin Actavis

Active Ingredient:
Moxonidine
Origin:
EU

Moxonidin Actavis (Moxonidine)

Moxonidine, the active ingredient in Moxonidin Actavis, is a imidazoline receptor agonist presented as an oral tablet for oral use. It treats essential hypertension in adult patients.
GNH India supplies Moxonidin Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxonidine acts on central imidazoline I1 receptors to lower blood pressure in hypertensive disorders.
  • Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension.
  • Resistant hypertension: may be added when blood pressure remains uncontrolled despite other antihypertensive agents.

How It Works

  • Moxonidine selectively stimulates central imidazoline I1 receptors, which attenuate sympathetic outflow from the brainstem. This reduction in sympathetic activity leads to decreased peripheral vascular resistance and lower cardiac output, resulting in a modest decline in arterial blood pressure.

Side Effects

Moxonidine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Dry mouth: sensation of oral dryness.
  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: light‑headedness, especially on standing.
  • Nausea: mild stomach upset.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure requiring medical attention.
  • Bradycardia: unusually slow heart rate.
  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Hepatic dysfunction: abnormal liver enzyme elevations.
  • Cardiac arrhythmia: irregular heart rhythm.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: use with caution; observe liver function tests.
  • Concomitant antihypertensives: risk of additive blood‑pressure lowering effects.
  • Pregnancy: safety not established; avoid unless clearly indicated.
  • Elderly patients: increased risk of dizziness and falls; monitor closely.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Moxonidine may interact with several drug classes; review patient medication lists.

Major Interactions (Avoid)

  • Other central antihypertensives (e.g., clonidine): may cause severe hypotension.
  • Potent CYP2D6 inhibitors: can increase moxonidine plasma concentrations.
  • Diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may diminish antihypertensive effect.
  • Beta‑blockers: may mask tachycardia associated with hypotension.

Frequently Asked Questions

Moxonidin Actavis contains moxonidine, which is prescribed to lower high blood pressure in adults with essential hypertension by reducing sympathetic nervous system activity.

Moxonidine selectively activates central imidazoline I1 receptors, decreasing sympathetic outflow from the brain. This leads to reduced peripheral vascular resistance and a modest fall in arterial pressure.

The appropriate dose of Moxonidin Actavis is determined by the prescribing healthcare professional based on the individual’s clinical condition, response, and any concomitant therapies.

Safety of moxonidine in pregnancy or while breastfeeding has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant.

Submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Moxonidine is a centrally acting imidazoline agonist, offering a modest blood‑pressure reduction with a lower incidence of metabolic side effects compared with some beta‑blockers or diuretics, but it may be combined with other classes for additive effect.

Store the product at room temperature, below 25 °C, in the original packaging. Protect it from moisture and direct light to maintain stability.

Moxonidin Actavis is taken orally, usually once daily, with or without food, as directed by the prescribing clinician.

Serious risks include severe hypotension, bradycardia, allergic reactions, hepatic dysfunction, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as fainting, rapid weight gain, jaundice, or irregular heartbeat.

Moxonidin Actavis should be avoided in patients with known hypersensitivity to moxonidine, severe hepatic impairment, or in those where a significant drop in blood pressure could be hazardous, such as certain cardiac conditions, unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT